NCT04664933View on ClinicalTrials.gov

Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET)

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Stroke, IschemicIntravascular ThrombosisMechanical Thrombectomy
Interventions
DRUG

Intra-arterial administration of neuroprotective agents

Intra-arterial administration of 3-n-butylphthalide for 16 to 24 hours during and after the operation at 17.36 to 26.04 ug/min

Trial Locations (1)

110016

RECRUITING

Department of Neurology, General Hospital of Northern Theater Command, Shenyang

All Listed Sponsors
lead

Hui-Sheng Chen

OTHER